Medical Travel Update: Cosmetic Safety | 16 November 2026

Medical Travel Update: New Frown-Line Treatment Research and Questions to Ask Before Travelling
World Medi Group | 16 November 2026
New aesthetic-treatment research can generate attention, particularly when headlines suggest longer-lasting results. Understanding what researchers actually measured helps patients put those claims into perspective.
This week’s medical travel update examines a newly published trial of liquid botulinum toxin for frown lines, explains its limitations and outlines practical questions for patients considering treatment in Türkiye or North Cyprus.
10 November: New trial of liquid botulinum toxin for frown lines
On 10 November 2026, Plastic and Reconstructive Surgery published a randomised, double-blind trial investigating relabotulinumtoxinA, a ready-to-use liquid botulinum toxin formulation, for glabellar lines, the vertical lines between the eyebrows.
The study included 132 participants, with 99 receiving the treatment and 33 receiving a placebo. Researchers assessed changes in appearance, patient satisfaction and safety over 12 months.
At one month, 92.9% of treated participants reported an improvement, compared with 9.1% in the placebo group. Treatment-related adverse events were reported in 8.1% of participants and were described as mild. These findings describe the study population and do not guarantee an individual outcome or exclude less common risks. doi.org
Does a 12-month study mean results last a year?
The length of follow-up should not be confused with the duration of a consistent treatment effect.
Researchers reported improvement lasting through six months for most treated participants, with some continuing to show improvement beyond that point. However, patient ratings and clinicians’ assessments produced different results at later visits.
At 12 months, 37.8% reported an improvement on the patient-rated appearance scale, while 12.2% showed at least a one-grade improvement on the clinician-rated frown-line severity scale. These measures assess different aspects of the outcome. Neither supports a promise that everyone will experience a year-long effect. pubmed.ncbi.nlm.nih.gov
What the research does not establish
The trial compared the treatment with a placebo. It did not directly compare it with another botulinum toxin product, so it cannot establish that it works faster or lasts longer than competing treatments.
The publication also does not establish whether the product is authorised or available in Türkiye or North Cyprus. Local availability and authorisation need to be checked separately with the treating clinician.
A useful consultation should distinguish between the expected improvement, how long a measurable effect may remain and how satisfied a patient might feel afterwards. These outcomes can differ. doi.org
Medical travel update: the wider picture this week
The weekly review did not identify a verified consequential new change in medical-tourism regulations, major provider developments, package prices, treatment demand, or travel and payment arrangements affecting UK and European patients travelling to Türkiye or North Cyprus.
This is a limited research finding. It should not be interpreted as confirmation that every clinic’s services, prices or booking terms remain unchanged. No sufficiently consequential new North Cyprus development was verified for inclusion in this edition.
Previously reported accreditation requirements and travel guidance remain matters to check when planning treatment, even when there is no new announcement.
Türkiye travel guidance remains relevant
At the time of the 16 November review, the FCDO’s Türkiye travel advice showed 27 October 2026 as its latest update. Its regional-tensions guidance advises travellers in or passing through the Middle East to prepare for possible flight cancellations, airspace closures and disruption.
This does not establish that a particular journey to Istanbul is affected. Patients should check their destination, any connecting airports and their airline’s current information before departure. GOV.UK
Read the latest UK government travel advice for Türkiye. For North Cyprus itineraries, also consult the UK government’s Cyprus travel advice, including entry requirements.
Five questions to take to your consultation
Before deciding on aesthetic treatment abroad, ask:
Which treatment and product are you proposing, and why are they appropriate for me?
Is the product authorised locally for the proposed use?
What improvement is realistic, and what evidence supports the expected duration?
What are the risks, limitations and alternatives, including having no treatment?
Who will manage concerns after I return home, and what additional costs could apply?
Request written answers alongside your treatment information. If a provider refers to new research, ask how closely the study population and treatment match your own circumstances.
Planning your next step
Research can help you prepare better questions. Your individual assessment should explain how the evidence relates to your medical history, expectations and proposed care.
Before booking, clarify your practitioner’s qualifications, the treatment location, follow-up arrangements and the terms of your quotation. Allow time to consider the information before making a decision.
For information about arranging an individual consultation and understanding treatment and aftercare plans in Türkiye or North Cyprus, visit World Medi Group.
This article provides general information about published research and medical travel. It does not recommend a particular prescription medicine or replace advice from a qualified treating clinician.





Comments